Cancer drug development
This part of the business creates and tests medicines for blood cancers, centered on Oncopeptides’ own oncology drug program and related research work.
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Oncopeptides AB is a Swedish biotechnology company focused on treatments for blood cancers, especially multiple myeloma. Its main work is developing drugs that attack cancer cells in a different way from standard chemotherapy, with the goal of helping patients whose disease has come back or stopped responding to earlier treatment.
The company makes money by selling its cancer medicines to hospitals, clinics, and specialty distributors in the markets where those products are approved. It also invests in research and clinical development to improve existing therapies and build a pipeline of follow-on drug candidates. In this kind of business, success depends on winning regulatory approvals, proving clinical value, and getting doctors and hospitals to adopt the treatment.
What makes Oncopeptides different is that it sits in a narrow but important part of the drug industry: late-stage cancer care. Rather than selling broad consumer products, it focuses on a single disease area where patients often need new options after other treatments fail. That gives the company a clear specialty, but it also means its future depends heavily on the clinical and commercial performance of a small number of medicines.
We rebuilt our DCF valuation models from the ground up and upgraded how Intrinsic Value is calculated. Alpha Spread now selects the method that best fits each company.
You can now see how the new methodology performed across thousands of stocks on our new Valuation Backtest page. We update the results at the end of every month.
New to Alpha Spread? Create free account
By using Alpha Spread you are agreeing to our Terms of Service and Privacy Policy.
Already have an account? Sign in
Stock intrinsic value is the real worth of a company's stock, based on its financial health and performance.
Instead of looking at the stock's current market price, which can change due to people's opinions and emotions, intrinsic value helps us understand if a stock is truly a good deal or not.
By focusing on the company's actual financial strength, like its earnings and debts, we can make better decisions about which stocks to buy and when.
Read more